Could a drug combo cure hepatitis b in kids? new trial aims to find out

NCT ID NCT07345624

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving two antiviral drugs—entecavir followed by pegylated interferon—can help children aged 3 to 6 with chronic hepatitis B achieve a functional cure (clearing the virus from the blood). About 80 children will be randomly assigned to receive either entecavir alone or entecavir plus the second drug. The goal is to see if the combination leads to better long-term virus control and possible cure, though lifelong monitoring may still be needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.